Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.03−0.38 (-4.52%)
Close on Nov 18, 2026Market cap $466.86MP/E –Yield –
Capricor Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Capricor Therapeutics's pe ratio was 41.9× on Jan 31, 2019, against 160.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jan 31, 2019 | 41.9× | +8.2 |
| 2018 | Dec 31, 2018 | 33.7× | −126.3 |
| 2013 | Jan 31, 2013 | 160.0× | +93.3 |
| 2012 | Dec 31, 2012 | 66.7× | −201.1 |
| 2011 | Dec 30, 2011 | 267.7× | – |
See a number that looks wrong?